Premium
Clinical C3 Inhibition With AMY‐101 Reveals Novel Insights Into IL‐8 ‐Driven Inflammation in COVID‐19
Author(s) -
Antoniadou Christina,
Natsi AnastasiaMaria,
Mastellos Dimitrios C.,
Papadimitriou Evangelos,
Gavriilidis Efstratios,
Tsironidou Victoria,
Papadopoulos Vasileios,
Eftalitsidis Evgenios,
Κoffa Μaria,
HuberLang Markus,
Risitano Antonio M.,
Yancopoulou Despina,
Germanidis Georgios,
Ritis Konstantinos,
Lambris John D.,
Skendros Panagiotis
Publication year - 2025
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/imm.13930
Subject(s) - covid-19 , medicine , disease , infectious disease (medical specialty)